Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.
Tomohiro IwasawaTakeo KosakaYota YasumizuHiroshi HongoYoshinori YanaiYuto BabaKazuhiro MatsumotoKohei NakamuraHiroshi NishiharaMototsugu OyaPublished in: International journal of clinical oncology (2022)
This is the first Japanese prostate cancer case series with CDK12 alterations. CDK12-altered prostate cancer is a heterogeneous disease, and accumulating cases with detailed information leads to precision oncology.